569 related articles for article (PubMed ID: 24760441)
1. Angiotensin II and vascular injury.
Montezano AC; Nguyen Dinh Cat A; Rios FJ; Touyz RM
Curr Hypertens Rep; 2014 Jun; 16(6):431. PubMed ID: 24760441
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II and the vascular phenotype in hypertension.
Savoia C; Burger D; Nishigaki N; Montezano A; Touyz RM
Expert Rev Mol Med; 2011 Mar; 13():e11. PubMed ID: 21450123
[TBL] [Abstract][Full Text] [Related]
3. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II.
Touyz RM
Exp Physiol; 2005 Jul; 90(4):449-55. PubMed ID: 15890798
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species and angiotensin II signaling in vascular cells -- implications in cardiovascular disease.
Touyz RM
Braz J Med Biol Res; 2004 Aug; 37(8):1263-73. PubMed ID: 15273829
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II, NADPH oxidase, and redox signaling in the vasculature.
Nguyen Dinh Cat A; Montezano AC; Burger D; Touyz RM
Antioxid Redox Signal; 2013 Oct; 19(10):1110-20. PubMed ID: 22530599
[TBL] [Abstract][Full Text] [Related]
6. Redox signaling in hypertension.
Paravicini TM; Touyz RM
Cardiovasc Res; 2006 Jul; 71(2):247-58. PubMed ID: 16765337
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation.
Bruder-Nascimento T; Chinnasamy P; Riascos-Bernal DF; Cau SB; Callera GE; Touyz RM; Tostes RC; Sibinga NE
J Mol Cell Cardiol; 2014 Jan; 66():18-26. PubMed ID: 24445059
[TBL] [Abstract][Full Text] [Related]
8. Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension.
Touyz RM; Tabet F; Schiffrin EL
Clin Exp Pharmacol Physiol; 2003 Nov; 30(11):860-6. PubMed ID: 14678251
[TBL] [Abstract][Full Text] [Related]
9. Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR.
Tabet F; Schiffrin EL; Callera GE; He Y; Yao G; Ostman A; Kappert K; Tonks NK; Touyz RM
Circ Res; 2008 Jul; 103(2):149-58. PubMed ID: 18566342
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells.
Touyz RM; Yao G; Viel E; Amiri F; Schiffrin EL
J Hypertens; 2004 Jun; 22(6):1141-9. PubMed ID: 15167449
[TBL] [Abstract][Full Text] [Related]
11. Diallyl Trisulfide Suppresses Angiotensin II-Induced Vascular Remodeling Via Inhibition of Mitochondrial Fission.
Lu ZY; Qi J; Yang B; Cao HL; Wang RY; Wang X; Chi RF; Guo CL; Yang ZM; Liu HM; Li B
Cardiovasc Drugs Ther; 2020 Oct; 34(5):605-618. PubMed ID: 32564303
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in angiotensin II signaling.
Touyz RM; Berry C
Braz J Med Biol Res; 2002 Sep; 35(9):1001-15. PubMed ID: 12219172
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy.
Zuo L; Ushio-Fukai M; Ikeda S; Hilenski L; Patrushev N; Alexander RW
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1824-30. PubMed ID: 15976327
[TBL] [Abstract][Full Text] [Related]
14. Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro.
Ren L; Liu N; Zhi H; Li Y; Li Y; Tang R; Sheng Z
Cardiovasc Diabetol; 2011 Jan; 10():10. PubMed ID: 21269478
[TBL] [Abstract][Full Text] [Related]
15. Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats.
Savoia C; Tabet F; Yao G; Schiffrin EL; Touyz RM
J Hypertens; 2005 May; 23(5):1037-45. PubMed ID: 15834290
[TBL] [Abstract][Full Text] [Related]
16. Vascular smooth muscle Jak2 mediates angiotensin II-induced hypertension via increased levels of reactive oxygen species.
Kirabo A; Kearns PN; Jarajapu YP; Sasser JM; Oh SP; Grant MB; Kasahara H; Cardounel AJ; Baylis C; Wagner KU; Sayeski PP
Cardiovasc Res; 2011 Jul; 91(1):171-9. PubMed ID: 21354995
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
Montezano AC; Callera GE; Yogi A; He Y; Tostes RC; He G; Schiffrin EL; Touyz RM
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1511-8. PubMed ID: 18467645
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in intracellular signalling in hypertension.
Touyz RM
Curr Opin Nephrol Hypertens; 2003 Mar; 12(2):165-74. PubMed ID: 12589177
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species.
Viedt C; Soto U; Krieger-Brauer HI; Fei J; Elsing C; Kübler W; Kreuzer J
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):940-8. PubMed ID: 10764657
[TBL] [Abstract][Full Text] [Related]
20. The GTPase ARF6 Controls ROS Production to Mediate Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation.
Bourmoum M; Charles R; Claing A
PLoS One; 2016; 11(1):e0148097. PubMed ID: 26824355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
